These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 6196340)
1. EBV transformed B cell lines present to antigen specific T cell clones determinants different from those recognized by antibody in an HLA-DR linked restricted fashion. Chu E; Umetsu D; Yunis E; Geha RS Hum Immunol; 1983 Nov; 8(3):217-26. PubMed ID: 6196340 [TBL] [Abstract][Full Text] [Related]
2. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells. Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319 [TBL] [Abstract][Full Text] [Related]
3. Specific B lymphocytes efficiently pick up, process and present antigen to T cells. Lanzavecchia A; Bove S Behring Inst Mitt; 1985 Aug; (77):82-7. PubMed ID: 3002320 [TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation. Chu E; Umetsu D; Rosen F; Geha RS J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142 [TBL] [Abstract][Full Text] [Related]
5. Antigen presentation by EBV-B cells to resting and activated T cells: role of interleukin 1. Chu ET; Lareau M; Rosenwasser LJ; Dinarello CA; Geha RS J Immunol; 1985 Mar; 134(3):1676-81. PubMed ID: 2981918 [TBL] [Abstract][Full Text] [Related]
6. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926 [TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex (MHC) restricted antigen recognition: high frequency of human T-cell clones recognizing novel MHC class II determinants. Nisbet-Brown E; Lee JW; Letarte M; Falk JA; Gelfand EW Hum Immunol; 1987 May; 19(1):41-52. PubMed ID: 2438261 [TBL] [Abstract][Full Text] [Related]
8. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line. Yamamoto M; Yano A J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the failure of resting B cells to present tetanus toxoid antigen to T cells. Brozek C; Umetsu D; Schneeberger E; Geha RS J Immunol; 1984 Mar; 132(3):1144-50. PubMed ID: 6607279 [TBL] [Abstract][Full Text] [Related]
10. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells. Roberts JL; Volkman DJ; Buckley RH J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604 [TBL] [Abstract][Full Text] [Related]
13. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells. Issekutz T; Chu E; Geha RS J Immunol; 1982 Oct; 129(4):1446-50. PubMed ID: 6286767 [TBL] [Abstract][Full Text] [Related]
14. Induction of IgG and IgE synthesis in normal B cells by autoreactive T cell clones. Leung DY; Young MC; Geha RS J Immunol; 1986 Apr; 136(8):2851-5. PubMed ID: 2937838 [TBL] [Abstract][Full Text] [Related]
15. Antigen-specific and polyclonal immunoglobulin production induced by a cloned tetanus toxoid-specific T cell line. Friedman SM; Principato MA; Thompson GS; Teichman F J Immunol; 1983 Mar; 130(3):1164-70. PubMed ID: 6185573 [TBL] [Abstract][Full Text] [Related]
16. HLA-DR-4-associated alloreactivity of an HLA-DR-3-restricted human tetanus toxoid-specific T cell clone: inhibition of both reactivities by an alloantiserum. Umetsu DT; Yunis EJ; Matsui Y; Jabara HH; Geha RS Eur J Immunol; 1985 Apr; 15(4):356-61. PubMed ID: 3157581 [TBL] [Abstract][Full Text] [Related]
17. Antigen recognition by MHC-incompatible cells of a human mismatched chimera. Roncarolo MG; Yssel H; Touraine JL; Bacchetta R; Gebuhrer L; De Vries JE; Spits H J Exp Med; 1988 Dec; 168(6):2139-52. PubMed ID: 2462006 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells. Howard DR; Eaves AC; Takei F Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652 [TBL] [Abstract][Full Text] [Related]
19. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules. Chen BP; DeMars R; Hank JA; Sondel PM Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068 [TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]